Riley Jeffrey Scott
Insider CIK 1487645 · GANX Director · AEN Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GANX Gain Therapeutics, Inc. | A Award deriv | 2026-07-15 | 2026-07-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| GANX Gain Therapeutics, Inc. | A Award deriv | 2025-06-24 | 2025-06-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GANX Gain Therapeutics, Inc. | A Award deriv | 2024-06-24 | 2024-06-26 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GANX Gain Therapeutics, Inc. | P Buy | 2024-03-28 | 2024-04-01 | 30,000 | $3.86 | $115.8K | 30,000 | SEC↗ |
| GANX Gain Therapeutics, Inc. | A Award deriv | 2023-06-23 | 2023-06-26 | 10,500 | — | $0 | 10,500 | SEC↗ |
| GANX Gain Therapeutics, Inc. | A Award deriv | 2022-09-20 | 2022-09-22 | 10,500 | — | $0 | 10,500 | SEC↗ |
| SYN Synthetic Biologics, Inc. | A Award deriv | 2016-11-30 | 2016-12-02 | 1,129,000 | — | $0 | 1,129,000 | SEC↗ |
| SYN Synthetic Biologics, Inc. | A Award deriv | 2015-12-04 | 2015-12-04 | 500,000 | — | $0 | 500,000 | SEC↗ |
| SYN Synthetic Biologics, Inc. | A Award deriv | 2015-01-08 | 2015-01-12 | 350,000 | — | $0 | 350,000 | SEC↗ |
| SYN Synthetic Biologics, Inc. | A Award deriv | 2014-04-17 | 2014-04-21 | 500,000 | — | $0 | 500,000 | SEC↗ |
| SYN Synthetic Biologics, Inc. | P Buy | 2013-01-07 | 2013-01-07 | 5 | $1.71 | $9 | 7,505 | SEC↗ |
| SYN Synthetic Biologics, Inc. | P Buy | 2013-01-07 | 2013-01-07 | 2,895 | $0.17 | $492 | 10,400 | SEC↗ |
| SYN Synthetic Biologics, Inc. | P Buy | 2013-01-03 | 2013-01-03 | 2,800 | $1.75 | $4.9K | 5,500 | SEC↗ |
| SYN Synthetic Biologics, Inc. | P Buy | 2013-01-03 | 2013-01-04 | 2,000 | $1.71 | $3.4K | 7,500 | SEC↗ |
| SYN Synthetic Biologics, Inc. | P Buy | 2013-01-02 | 2013-01-03 | 2,700 | $1.78 | $4.8K | 2,700 | SEC↗ |
| AEN ADEONA PHARMACEUTICALS, IN | A Award deriv | 2012-02-03 | 2012-02-06 | 750,000 | — | $0 | 908,333 | SEC↗ |